This site is intended for health professionals only

Editor’s pick

Lundbeck initiates clinical phase II trials
Lundbeck initiates clinical phase II trials
Novartis to develop Incyte drugs
Novartis to develop Incyte drugs
Cancer drug approved in North East
Cancer drug approved in North East
WHO “still confident in Tamiflu”
WHO “still confident in Tamiflu”
Tumour shrinkage leads to more curative surgery
Tumour shrinkage leads to more curative surgery
Awry gene linked to mental illness
Awry gene linked to mental illness
Vioxx heart risk “was well known”
Vioxx heart risk “was well known”
bioProcessUK presents inaugural Peter Dunnill Award
bioProcessUK presents inaugural Peter Dunnill Award
Cetuximab “boosts cancer outcomes”
Cetuximab “boosts cancer outcomes”
Six allergic reactions to H1N1 jab
Six allergic reactions to H1N1 jab
bioProcessUK welcomes investment in bioprocessing research
bioProcessUK welcomes investment in bioprocessing research
NicOx launches €70m rights issue
NicOx launches €70m rights issue
1 … 97 98 99 100 101 … 302





Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2026
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x